Abstract:Aims: Circulating microparticles (MPs) from metabolic syndrome patients and those generated from apoptotic T-cells induce endothelial dysfunction; however, the molecular and cellular mechanism(s) underlying in the effects of MPs remain to be elucidated. Results: Here, we show that both types of MPs increased expression of endoplasmic reticulum (ER) stress markers XBP-1, p-eIF2alpha and CHOP and nuclear translocation of ATF6 on human aortic endothelial cells. MPs decreased in vitro nitric oxide release by human… Show more
“…ER stress may be mediated by increased oxidative stress and vice-versa 21, 37, 38. Here we sought to determine whether HG and IL-1β perturb ER function in a MAO-dependent manner.…”
Section: Resultsmentioning
confidence: 99%
“…There is
an association between oxidative and ER stress, but whether mitochondrial ROS
formation is upstream of ER stress or vice-versa was not clear. Activation of the
UPR under stress conditions leads to impaired Ca 2+ and redox
homeostasis 21, 38. Hence, oxidative stress is increased leading to impaired
mitochondrial function.…”
Monoamine oxidase (MAO) inhibitors ameliorate contractile function in diabetic animals,
but the mechanisms remain unknown. Equally elusive is the interplay between the
cardiomyocyte alterations induced by hyperglycemia and the accompanying
inflammation. Here we show that exposure of primary cardiomyocytes to high
glucose and pro-inflammatory stimuli leads to MAO-dependent increase in reactive
oxygen species that causes permeability transition pore opening and
mitochondrial dysfunction. These events occur upstream of endoplasmic reticulum
(ER) stress and are abolished by the MAO inhibitor pargyline, highlighting the
role of these flavoenzymes in the ER/mitochondria cross-talk. In
vivo, streptozotocin administration to mice induced oxidative
changes and ER stress in the heart, events that were abolished by pargyline.
Moreover, MAO inhibition prevented both mast cell degranulation and altered
collagen deposition, thereby normalizing diastolic function. Taken together,
these results elucidate the mechanisms underlying MAO-induced damage in diabetic
cardiomyopathy and provide novel evidence for the role of MAOs in inflammation
and inter-organelle communication. MAO inhibitors may be considered as a
therapeutic option for diabetic complications as well as for other disorders in
which mast cell degranulation is a dominant phenomenon.
“…ER stress may be mediated by increased oxidative stress and vice-versa 21, 37, 38. Here we sought to determine whether HG and IL-1β perturb ER function in a MAO-dependent manner.…”
Section: Resultsmentioning
confidence: 99%
“…There is
an association between oxidative and ER stress, but whether mitochondrial ROS
formation is upstream of ER stress or vice-versa was not clear. Activation of the
UPR under stress conditions leads to impaired Ca 2+ and redox
homeostasis 21, 38. Hence, oxidative stress is increased leading to impaired
mitochondrial function.…”
Monoamine oxidase (MAO) inhibitors ameliorate contractile function in diabetic animals,
but the mechanisms remain unknown. Equally elusive is the interplay between the
cardiomyocyte alterations induced by hyperglycemia and the accompanying
inflammation. Here we show that exposure of primary cardiomyocytes to high
glucose and pro-inflammatory stimuli leads to MAO-dependent increase in reactive
oxygen species that causes permeability transition pore opening and
mitochondrial dysfunction. These events occur upstream of endoplasmic reticulum
(ER) stress and are abolished by the MAO inhibitor pargyline, highlighting the
role of these flavoenzymes in the ER/mitochondria cross-talk. In
vivo, streptozotocin administration to mice induced oxidative
changes and ER stress in the heart, events that were abolished by pargyline.
Moreover, MAO inhibition prevented both mast cell degranulation and altered
collagen deposition, thereby normalizing diastolic function. Taken together,
these results elucidate the mechanisms underlying MAO-induced damage in diabetic
cardiomyopathy and provide novel evidence for the role of MAOs in inflammation
and inter-organelle communication. MAO inhibitors may be considered as a
therapeutic option for diabetic complications as well as for other disorders in
which mast cell degranulation is a dominant phenomenon.
“…The membranes were then washed at least three times in Tris buffer solution containing 0.05% Tween and incubated for 1 hour per wash at room temperature, with the appropriate horseradish peroxidase- (HRP-) conjugated secondary antibody (Amersham). The protein antibody complexes were detected by ECL plus (Amersham) according to the protocol of the manufacturer as previously done [29, 30]. …”
The aim of this work was to study the vascular effects of dietary supplementation of a nonalcoholic red wine polyphenol extract, Provinols, in Zucker fatty (ZF) obese rats. ZF or lean rats received diet supplemented or not with Provinols for 8 weeks. Vasoconstriction in response to phenylephrine (Phe) was then assessed in small mesenteric arteries (SMA) and the aorta with emphasis on the contribution of cyclooxygenases (COX). Although no difference in vasoconstriction was observed between ZF and lean rats both in SMA and the aorta, Provinols affected the contribution of COX-derived vasoconstrictor agents. The nonselective COX inhibitor, indomethacin, reduced vasoconstriction in vessels from both groups; however, lower efficacy was observed in Provinols-treated rats. This was associated with a reduction in thromboxane-A2 and 8-isoprostane release. The selective COX-2 inhibitor, NS398, reduced to the same extent vasoconstriction in aortas from ZF and Provinols-treated ZF rats. However, NS398 reduced response to Phe only in SMA from ZF rats. This was associated with a reduction in 8-isoprostane and prostaglandin-E release. Paradoxically, Provinols decreased COX-2 expression in the aorta, while it increased its expression in SMA. We provide here evidence of a subtle and paradoxical regulation of COX pathway by Provinols vessels from obese rats to maintain vascular tone within a physiological range.
“…La contribution des vésicules extracellulaires plasmatiques à la dysfonction endothéliale souvent associée au SMet a été évaluée dans des expériences dans lesquelles des VE isolées à partir du plasma de patients souffrant ou non de SMet ont été injectées par voie intraveineuse à des souris. Dans ces conditions, les VE de patients présentant un SMet, comparées à des VE isolées d'individus sains, induisent chez les souris des altérations de la réponse de l'aorte à l'acétylcholine [29,30]. Cette réponse cellulaire induite par les VE de patients repose sur la voie de signalisation Fas/ligand de Fas [30], à l'origine de la production d'espèces réactives de l'oxygène (ERO) dépendant de l'activation de la sphingomyélinase neutre [29].…”
Section: Effets Vasculairesunclassified
“…Dans ces conditions, les VE de patients présentant un SMet, comparées à des VE isolées d'individus sains, induisent chez les souris des altérations de la réponse de l'aorte à l'acétylcholine [29,30]. Cette réponse cellulaire induite par les VE de patients repose sur la voie de signalisation Fas/ligand de Fas [30], à l'origine de la production d'espèces réactives de l'oxygène (ERO) dépendant de l'activation de la sphingomyélinase neutre [29]. Par ailleurs, des concentrations élevées de glucose ou d'angiotensine-II augmentent la production de MV endothéliales présentant un potentiel pro-oxydant, pro-coagulant et pro-inflammatoire [31,32].…”
> Les vésicules extracellulaires (VE) suscitent un intérêt croissant lié à leur capacité à transférer du contenu biologique entre cellules. Les VE, émises dans l'espace extracellulaire, circulent via les différents fluides de l'organisme et modulent localement ou à distance les réponses des cellules avec lesquelles elles ont interagi. Des données cliniques et expérimentales étayent leur rôle dans les maladies liées au syndrome métabolique. Les VE bousculent la vision traditionnelle de la communication intercellulaire et représentent ainsi un mode de communication alternatif et versatile, qui ouvre la porte à de nouveaux concepts et opportunités tant biologiques que thérapeutiques. < intraluminales formées lors de la maturation des corps multivésiculaires (CMV). Elles sont sécrétées dans le milieu extracellulaire après fusion des CMV avec la membrane plasmique [1]. Leur formation implique l'assemblage de quatre complexes ESCRT (endosomal sorting complex required for transport) [1]. La biogenèse exosomale, initiée par l'accumulation de tétraspanines (CD9 et CD63) dans la membrane endosomale, est suivie du recrutement séquentiel d'ESCRT-0 et d'ESCRT-I, qui vont ségréger des cargos transmembranaires ubiquitinylés. Le recrutement du sous-complexe ESCRT-III, via ESCRT-II, induit ensuite la courbure et la fission des vésicules intraluminales (à l'origine des futurs exosomes). Une voie connexe de formation des exosomes implique les protéines syndecans et synténine, mais la participation des ESCRT dans les mécanismes régissant la sortie de ces cargos reste à déterminer. Une formation d'exosomes indépendante du complexe ESCRT a été décrite ; elle fait intervenir une régulation par les tétraspanines (CD9, CD63 ou CD81) et certains lipides (des céramides) [2]. L'adressage à la membrane des exosomes formés dans les CMV et leur sécrétion engagent des protéines de trafic membranaire de la famille des petites protéines G (GTPases), telles que Rab11, Rab35 et Rab27. Alors que Rab11 et Rab35 réguleraient le trafic des vésicules endosomales précoces vers la membrane plasmique, Rab 27 interviendrait plutôt dans l'adressage à la membrane cellulaire des endosomes tardifs (lysosomes) [3]. Les exosomes participent à de nombreuses réponses physiopathologiques. Plusieurs études ont ainsi démontré leur capacité à réguler la
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.